3-MeO-PCE

3-MeO-PCE is covered as an arylcyclohexylamine under Austria’s Neue-Psychoaktive-Substanzen-Verordnung. The ordinance treats every substance within the chemical definitions in Anlage II as a new psychoactive substance; the current arylcyclohexylamine definition has applied since 19 April 2024. For profit, producing, importing, exporting, supplying, or procuring such a substance for psychoactive use in humans is punishable by up to two years’ imprisonment under the Neue-Psychoaktive-Substanzen-Gesetz.

Chile controls 3-MeO-PCE under the Ley 20.000 framework because Article 1 of Decreto 867 expressly lists Eticiclidina (PCE) and generically includes the isomers, esters and ethers of listed substances; 3-MeO-PCE is covered by that rule rather than separately named. Unauthorized manufacture, preparation or extraction of an Article 1 substance is punished under Ley 20.000 Article 1 by presidio mayor in its minimum to medium degrees and a 40–400 UTM fine; Article 3 applies those penalties to trafficking and defines trafficking to include, among other conduct, unauthorized import, export, transport, acquisition, transfer, possession, supply, storage or carrying. For unauthorized possession, transport, storage or carrying of small quantities, Article 4 provides presidio menor in its medium to maximum degrees and a 10–40 UTM fine, subject to the statutory medical-treatment or exclusive, proximate personal-use justification and the court's assessment of trafficking purpose. These are conduct-specific statutory ranges, not a blanket claim that every possession fact receives the Article 1 penalty. The official Directemar compilation is expressly marked last updated September 2023, and no later substance-list amendment to Decreto 867 is identified in official Chilean sources. The current version of Ley 20.000 includes an amendment dated 23 May 2026. No separate Chilean entry names 3-MeO-PCE; Article 1 coverage is based on the compound's structure.

Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) since July 18, 2019. Production, import for market distribution, administration to others, and trading are punishable offenses.²³ Possession is prohibited but not subject to criminal penalty.²³

3-MeO-PCE (3-metoksyetycyklidyna) is listed as a Group II-P psychotropic substance in Poland. Possession without authorization is punishable by imprisonment for up to three years, and unauthorized manufacture, processing, or conversion is punishable by imprisonment for up to three years.

Singapore lists 3-MeO-PCE, also called 3-methoxyeticyclidine, as a Class A controlled drug in the First Schedule to the Misuse of Drugs Act 1973. The listing has applied since 1 June 2024 and includes the methoxy positional isomers in the phenyl ring. The Act prohibits unauthorised possession, consumption, trafficking, manufacture, import and export of controlled drugs.

Classified as a controlled substance.¹¹ Possession, production, and distribution are prohibited under national drug legislation.¹¹

Specifically named as a controlled substance under Verzeichnis E of Swiss narcotics legislation.

As of 28 August 2026, 3-MeO-PCE is illegal in Turkey. Decision No. 2013/5742 was dated 16 December 2013 and published on 25 January 2014 in Official Gazette No. 28893; Annex 2 item 109 lists ‘3-MeO-PCE ... 3-Methoxyeticyclidine’. The principal framework includes Law No. 2313 and TCK Articles 188, 190 and 191. The EWS mechanism brings NPS under Law No. 2313, and the current official 2025 Türkiye Uyuşturucu Raporu reports that 1,078 NPS had been brought under that law through 31 July 2025. Turkey began generic classification in 2015, and 453 of those 1,078 substances were controlled through generic classification. 3-MeO-PCE is expressly named in the 2013/5742 annex. The Turkish Penal Code, as published by the Ministry of Justice, provides that unauthorized manufacture/import/export falls under Article 188(1) (20–30 years' imprisonment and 2,000–20,000 days' judicial fine); domestic sale, offer, giving, dispatch, transport, storage, purchase, acceptance or possession falls under Article 188(3) (at least 10 years' imprisonment and 1,000–20,000 days' judicial fine); personal-use purchase, acceptance, possession or use falls under Article 191(1) (2–5 years' imprisonment), with Article 191(2)–(3) postponement, supervision and possible treatment rules. Article 188(4)(a) lists enhanced-penalty categories, but 3-MeO-PCE's arylcyclohexylamine/PCE identity alone does not establish that an enhancement applies. The historical exact annex listing appears in the official Narkotik report, while current official Narkotik materials describe the continuing Law No. 2313/NPS framework. Product-specific licensing, quantity, evidentiary and charging questions remain unresolved.

Ukraine lists 3-MeO-PCE (3-Methoxyeticyclidine) in List No. 2 of Table I to Cabinet of Ministers Resolution No. 770. List No. 2 is the list of particularly dangerous psychotropic substances whose circulation is prohibited.

Controlled under the Misuse of Drugs Act 1971. Covered by the arylcyclohexylamine generic clause added via S.I. 2013/239, effective February 26, 2013.³⁰ This clause encompasses N-alkyl derivatives of 1-phenylcyclohexylamine with alkoxy substitution in the phenyl ring.³⁰ Possession, production, supply, and import are illegal.

Finland lists 3-MeO-PCE (3-metoksietisyklidiini) as a psychoactive substance prohibited from the consumer market in the annex to Government Decree 1130/2014. The decree makes the listed substance a consumer-market-prohibited psychoactive substance; this is a consumer-market control rather than a narcotics-schedule designation.